UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Properties, production and applications of camelid single-domain antibody fragments

Applied microbiology and biotechnology, 2007-11, Vol.77 (1), p.13-22

2007

Volltextzugriff (PDF)

A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies

The Journal of biological chemistry, 1999-06, Vol.274 (26), p.18218-18230

1999

Volltextzugriff (PDF)

Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins

Journal of Virology, 1993-07, Vol.67 (7), p.3908-3916

1993

Volltextzugriff (PDF)

Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding

Protein engineering, 1998-12, Vol.11 (12), p.1267-1276

1998

Volltextzugriff (PDF)

Fibrinogen fragments X, Y, D and E increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats

Thrombosis and haemostasis, 1985, Vol.53 (2), p.212

1985

Volltextzugriff (PDF)

Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody

Human molecular genetics, 2006-01, Vol.15 (1), p.105-111

2006

Volltextzugriff (PDF)

Improved anti-IgG and HSA affinity ligands: Clinical application of VHH antibody technology

Journal of immunological methods, 2007-07, Vol.324 (1), p.1-12

2007

Volltextzugriff (PDF)

The influence of glucocorticoid on the fibrinogen messenger RNA content of rat liver in vivo and in hepatocyte suspension culture

Biochemical journal, 1984-06, Vol.220 (3), p.631-637

1984

Volltextzugriff (PDF)

Selection of Recombinant, Library-Derived Antibody Fragments against p24 for Human Immunodeficiency Virus Type 1 Diagnostics

Clinical and Diagnostic Laboratory Immunology, 1998-09, Vol.5 (5), p.636

1998

Volltextzugriff (PDF)

The influence of glucocorticoid on albumin synthesis and its messenger RNA in rat in vivo and in hepatocyte suspension culture

Biochimica et biophysica acta, 1985-01, Vol.824 (1), p.27

1985

Volltextzugriff (PDF)

Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open‐label feasibility trial

British journal of dermatology (1951), 2022-03, Vol.186 (3), p.429-439

2022

Volltextzugriff (PDF)

Llama Antibodies against a Lactococcal Protein Located at the Tip of the Phage Tail Prevent Phage Infection

Journal of Bacteriology, 2005-07, Vol.187 (13), p.4531-4541

2005

Volltextzugriff (PDF)

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Mucosal immunology, 2010-01, Vol.3 (1), p.49-56

2010

Volltextzugriff (PDF)

Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies

Scientific reports, 2022-08, Vol.12 (1), p.13413-13413, Article 13413

2022

Volltextzugriff (PDF)

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement

Nature communications, 2022-10, Vol.13 (1), p.6073-6073, Article 6073

2022

Volltextzugriff (PDF)

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

Neurology, 2019-06, Vol.92 (23), p.e2661

2019

Volltextzugriff (PDF)

PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES

HemaSphere, 2022-06, Vol.6 (Suppl), p.2175-2176

2022

Volltextzugriff (PDF)

Structural and functional similarities of bovine alpha-crystallin and mouse small heat-shock protein. A family of chaperones

The Journal of biological chemistry, 1993-01, Vol.268 (2), p.1046-1052

1993

Volltextzugriff (PDF)

ARGX-117, a therapeutic complement inhibiting antibody targeting C2

Journal of allergy and clinical immunology, 2021-04, Vol.147 (4), p.1420-1429.e7

2021

Volltextzugriff (PDF)

Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function

The Journal of immunology (1950), 2020-12, Vol.205 (12), p.3456-3467

2020

Volltextzugriff (PDF)

LB773 Treating pemphigus vulgaris (PV) and foliaceus (PF) by inhibiting the neonatal Fc receptor: Phase 2 multicentre open-label trial with efgartigimod

Journal of investigative dermatology, 2021-09, Vol.141 (9), p.B16-B16

2021

Volltextzugriff (PDF)

Llama antibody fragments have good potential for application as HIV type 1 topical microbicides

AIDS research and human retroviruses, 2012-02, Vol.28 (2), p.198

2012

Volltextzugriff (PDF)

Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display

European journal of human genetics : EJHG, 2005-06, Vol.13 (6), p.721-730

2005

Volltextzugriff (PDF)

Spontaneous peptide bond cleavage in aging alpha-crystallin through a succinimide intermediate

The Journal of biological chemistry, 1988-12, Vol.263 (35), p.19020-19023

1988

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(37)
Tagungsberichte
(1)

Sprache

Englisch
(38)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(26)
Animals
(18)
Humans
(18)
Biological And Medical Sciences
(16)
Fundamental And Applied Biological Sciences. Psychology
(13)
Biochemistry & Molecular Biology
(10)
Amino Acid Sequence
(9)
Immunology
(8)
Molecular Sequence Data
(8)
Male
(6)
Female
(5)
Medical Sciences
(5)
Mice
(5)
Microbiology
(5)
Proteins
(5)
Antibodies
(4)
Biotechnology & Applied Microbiology
(4)
Blotting, Western
(4)
Cattle
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Properties, production and applications of camelid single-domain antibody fragments

A Large Non-immunized Human Fab Fragment Phage Library That Permits Rapid Isolation and Kinetic Analysis of High Affinity Antibodies

Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins

Absolute conservation of residue 6 of immunoglobulin heavy chain variable regions of class IIA is required for correct folding

Fibrinogen fragments X, Y, D and E increase levels of plasma fibrinogen and liver mRNAs coding for fibrinogen polypeptides in rats

Prevention of oculopharyngeal muscular dystrophy-associated aggregation of nuclear poly(A)-binding protein with a single-domain intracellular antibody

Improved anti-IgG and HSA affinity ligands: Clinical application of VHH antibody technology

The influence of glucocorticoid on the fibrinogen messenger RNA content of rat liver in vivo and in hepatocyte suspension culture

Selection of Recombinant, Library-Derived Antibody Fragments against p24 for Human Immunodeficiency Virus Type 1 Diagnostics

The influence of glucocorticoid on albumin synthesis and its messenger RNA in rat in vivo and in hepatocyte suspension culture

Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open‐label feasibility trial

Llama Antibodies against a Lactococcal Protein Located at the Tip of the Phage Tail Prevent Phage Infection

Cusatuzumab for treatment of CD70‐positive relapsed or refractory cutaneous T‐cell lymphoma

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies

The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement

Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

PB2305: EFGARTIGIMOD: CLINICAL DEVELOPMENT OF A NOVEL FCRN ANTAGONIST IN THE TREATMENT OF AUTOIMMUNE DISEASES

Structural and functional similarities of bovine alpha-crystallin and mouse small heat-shock protein. A family of chaperones

ARGX-117, a therapeutic complement inhibiting antibody targeting C2

Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function

LB773 Treating pemphigus vulgaris (PV) and foliaceus (PF) by inhibiting the neonatal Fc receptor: Phase 2 multicentre open-label trial with efgartigimod

Llama antibody fragments have good potential for application as HIV type 1 topical microbicides

Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display

Spontaneous peptide bond cleavage in aging alpha-crystallin through a succinimide intermediate

Suchergebnisse filtern